Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suzetrigine in Total Knee Arthroplasty
NCT07624526Phase 4Not yet recruiting
- Sponsor
- Emory University
- Start
- Jul 2026
- Primary completion
- Aug 2028
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of suzetrigine in knee osteoarthritis (OA), sponsored by Emory University. Primary endpoints: Numeric Rating Scale, Average daily opioid consumption and 1 more. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
suzetrigine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT07624526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07624526.